3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow PATH Vaccine Solutions: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine SIIL LAIV (live, trivalent seasonal influenza vaccine), Placebo - Influenza | Phase 2 | Completed | PATH Vaccine Solutions | 309 | 2012-06-01 | 2015-06-01 |
| Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults Placebo, SPWCV+Alum 100 mcg, SPWCV+Alum 600 mcg - Pneumococcal Vaccines | Phase 1 | Completed | PATH Vaccine Solutions | 42 | 2012-02-01 | 2014-06-05 |
| Low-dose Challenge Model With Enterotoxigenic E Coli E coli strain H10407 and buffer, E coli H10407 and buffer - Diarrhea | Phase 1 | Completed | Johns Hopkins Bloomberg School of Public Health | 30 | 2009-02-01 | 2014-09-12 |
Diarrhea (1) · Influenza, Human (1)
Buffers (1)
United States (2) · Bangladesh (1)
Clayton Harro, M.D. (1) · Royce Morrison, M.D. (1) · W. Abdullah Brooks, MD, MPH (1)
PMID 21852546, PMID 29702652, PMID 30481269, PMID 30481272, PMID 30592459, PMID 31895881